NCT06064604Not yet recruiting
Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke
Clinical Trial: Powered Hip & Ankle Exoskeletons for Stroke Survivors With Gait Impairment
Source: ClinicalTrials.gov · Last updated 26 Nov 2025
Brief summary (registry, in English)
An exoskeleton device is a robotic system designed to improve an individual's ability to move and perform tasks encountered in everyday situations. These devices consist of external rigid limb segments that assists humans through different body movements with the use of actuators. These devices are controlled by an onboard computer that determines the timing and magnitude of assistance deployed to the user. Exoskeleton controller performance is key to providing beneficial assistance that does not inhibit the user's movement. Preceding work will compare the benefit of personalized hip versus ankle joint exoskeleton assistance for improvement of post-stroke gait. It will combine exoskeleton technology with the user's movement feedback to improve wearable robotic assistance to an individual stroke survivor's gait pattern. For the clinical trial research covered under this protocol, the investigator will test various exoskeleton technologies with stroke survivors in real-world contexts, indoors and outdoors, and measure clinically meaningful outcomes and user perceptions regarding technology usability and adoption. The long-term goal is to deploy self-adaptive, adoptable exoskeletons for personalized assistance during community ambulation.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 26 Sept 2023
- Start date
- Jan 2027
- Primary completion date
- Dec 2028
- Lead sponsor
- Georgia Institute of Technology
- Diseases
- Stroke
- NCT number
- NCT06064604
What you commit to
- Study type: Interventional
- Planned participants: 20
- From Jan 2027 to the primary completion date, Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Has a significant secondary deficit beyond stroke (e.g. amputation, legal blindness or other severe impairment or condition) that in the opinion of the Principal Investigator (PI), would likely affect the study outcome or confound the results
Other
- Requires a walker to walk independently
- Has a shuffling gait pattern overground
- Has a Functional Ambulation Category (FAC) score of 2 or lower (the participant requires the assistance of another person in order to walk)
- For exoskeleton-only studies, the exoskeleton device does not fit appropriately or safely, as determined by the research team during the fitting assessment.
Who the study is looking for
- Between 18-85 years of age
- Stroke at least 6 months prior to study involvement
- Community dwelling (participant does not live in an assisted living facility)
- Able to provide informed consent to participate in the study activities
- Can safely participate in the study activities (per self-report)
- Must have a Functional Ambulation Category (FAC) score of 3 or above (the participant can walk without the assistance of another person)
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Exoskeleton and Prosthetic Intelligent Controls Lab Coordinator of this site? Confirm its status | Atlanta | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.